Rollins Emily
SEC CIK 1847014 · EDGAR
BoughtSold
Most active insiders at XMTR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Altschuler Randolph | Dir | — | $8.92M |
| 2 | Biewald Lukas Alexander | Dir | $4.00M | — |
| 3 | Sahni Sanjeev Singh | Pres | — | $2.75M |
| 4 | Miln James | CFO | — | $2.74M |
| 5 | Dutt Subir | Chief Sales Off | — | $2.11M |
| 6 | Raghavan Vaidyanathan | CTO | — | $1.24M |
| 7 | Weymouth Katharine | Dir | $50.0K | $947.7K |
| 8 | Rosati Fabio | Dir | — | $911.2K |
| 9 | Rollins Emily | Dir | — | $593.4K |
| 10 | Azevedo Roy | Dir | — | — |
Transactions 49
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-08-21 16:28 | 2026-08-19 | XMTR | Xometry, Inc. | Rollins Emily | Dir | M - OptEx | $12.32 | +5,000 | 20.1K | +33% | +$61.6K |
| DMT | 2026-08-21 16:28 | 2026-08-19 | XMTR | Xometry, Inc. | Rollins Emily | Dir | S - Sale+OE | $84.31 | -5,000 | 15.1K | -25% | -$421.5K |
| T | 2026-04-03 17:11 | 2026-04-01 | DLB | Dolby Laboratories, Inc. | Rollins Emily | Dir | S - Sale | $60.08 | -1,000 | 12.5K | -7% | -$60.1K |
| DT | 2026-04-03 15:59 | 2026-04-01 | XMTR | Xometry, Inc. | Rollins Emily | Dir | M - OptEx | $12.32 | +1,000 | 16.1K | +7% | +$12.3K |
| DT | 2026-04-03 15:59 | 2026-04-01 | XMTR | Xometry, Inc. | Rollins Emily | Dir | S - Sale+OE | $42.02 | -1,000 | 15.1K | -6% | -$42.0K |
| 2026-03-12 | 2026-03-10 | XMTR | Xometry, Inc. | Rollins Emily | Dir | A - Grant | $0.00 | +3,681 | 15.1K | +32% | $0 | |
| 2026-02-05 | 2026-02-03 | DLB | Dolby Laboratories, Inc. | Rollins Emily | Dir | A - Grant | $0.00 | +3,908 | 13.5K | +41% | $0 | |
| DMT | 2026-01-06 | 2026-01-02 | XMTR | Xometry, Inc. | Rollins Emily | Dir | S - Sale+OE | $61.86 | -1,000 | 12.2K | -8% | -$61.9K |
| DT | 2026-01-06 | 2026-01-02 | XMTR | Xometry, Inc. | Rollins Emily | Dir | M - OptEx | $12.32 | +1,000 | 12.5K | +9% | +$12.3K |
| DT | 2025-11-12 | 2025-11-10 | XMTR | Xometry, Inc. | Rollins Emily | Dir | M - OptEx | $12.32 | +1,000 | 12.5K | +9% | +$12.3K |
| DMT | 2025-11-12 | 2025-11-10 | XMTR | Xometry, Inc. | Rollins Emily | Dir | S - Sale+OE | $68.02 | -1,000 | 12.2K | -8% | -$68.0K |
| D | 2025-08-12 | 2025-08-11 | XMTR | Xometry, Inc. | Rollins Emily | Dir | M - OptEx | $12.32 | +350 | 11.5K | +3% | +$4,312 |
| DM | 2025-05-09 | 2025-05-09 | XMTR | Xometry, Inc. | Rollins Emily | Dir | S - Sale+OE | $30.70 | -10.0K | 11.1K | -47% | -$308.3K |
| D | 2025-05-09 | 2025-05-09 | XMTR | Xometry, Inc. | Rollins Emily | Dir | M - OptEx | $12.32 | +5,000 | 21.1K | +31% | +$61.6K |
| MT | 2025-04-08 | 2025-04-07 | XMTR | Xometry, Inc. | Rollins Emily | Dir | S - Sale | $20.66 | -2,000 | 16.7K | -11% | -$41.3K |
| 2025-03-13 | 2025-03-11 | XMTR | Xometry, Inc. | Rollins Emily | Dir | A - Grant | $0.00 | +5,689 | 18.1K | +46% | $0 | |
| 2025-02-06 | 2025-02-04 | DLB | Dolby Laboratories, Inc. | Rollins Emily | Dir | A - Grant | $0.00 | +3,140 | 9,633 | +48% | $0 | |
| T | 2025-02-03 | 2025-01-30 | DLB | Dolby Laboratories, Inc. | Rollins Emily | Dir | S - Sale | $84.90 | -1,000 | 6,493 | -13% | -$84.9K |
| MT | 2024-11-12 | 2024-11-07 | XMTR | Xometry, Inc. | Rollins Emily | Dir | S - Sale | $29.49 | -3,729 | 13.1K | -22% | -$110.0K |
| 2024-03-05 | 2024-03-01 | DLB | Dolby Laboratories, Inc. | Rollins Emily | Dir | S - Sale | $80.88 | -1,000 | 7,493 | -12% | -$80.9K | |
| 2024-02-29 | 2024-02-27 | XMTR | Xometry, Inc. | Rollins Emily | Dir | A - Grant | $0.00 | +5,416 | 16.2K | +50% | $0 | |
| 2024-02-08 | 2024-02-06 | DLB | Dolby Laboratories, Inc. | Rollins Emily | Dir | A - Grant | $0.00 | +2,952 | 8,493 | +53% | $0 | |
| DT | 2024-01-29 | 2024-01-26 | XMTR | Xometry, Inc. | Rollins Emily | Dir | M - OptEx | $12.32 | +1,000 | 11.8K | +9% | +$12.3K |
| DT | 2024-01-29 | 2024-01-26 | XMTR | Xometry, Inc. | Rollins Emily | Dir | S - Sale+OE | $32.39 | -1,000 | 10.8K | -8% | -$32.4K |
| DMT | 2024-01-02 | 2023-12-29 | XMTR | Xometry, Inc. | Rollins Emily | Dir | S - Sale+OE | $36.83 | -1,000 | 10.8K | -8% | -$36.8K |
| DT | 2024-01-02 | 2023-12-29 | XMTR | Xometry, Inc. | Rollins Emily | Dir | M - OptEx | $12.32 | +1,000 | 11.8K | +9% | +$12.3K |
| DMT | 2023-12-05 | 2023-12-01 | XMTR | Xometry, Inc. | Rollins Emily | Dir | S - Sale+OE | $25.04 | -1,000 | 11.0K | -8% | -$25.0K |
| DT | 2023-12-05 | 2023-12-01 | XMTR | Xometry, Inc. | Rollins Emily | Dir | M - OptEx | $12.32 | +1,000 | 11.8K | +9% | +$12.3K |
| 2023-05-10 | 2023-05-08 | DLB | Dolby Laboratories, Inc. | Rollins Emily | Dir | S - Sale | $84.70 | -1,000 | 5,541 | -15% | -$84.7K | |
| 2023-03-23 | 2023-03-21 | XMTR | Xometry, Inc. | Rollins Emily | Dir | A - Grant | — | +7,041 | 10.8K | +189% | — | |
| 2023-03-03 | 2023-03-01 | DLB | Dolby Laboratories, Inc. | Rollins Emily | Dir | S - Sale | $82.04 | -1,000 | 6,541 | -13% | -$82.0K | |
| 2023-02-09 | 2023-02-07 | DLB | Dolby Laboratories, Inc. | Rollins Emily | Dir | A - Grant | $0.00 | +3,296 | 7,541 | +78% | $0 | |
| D | 2023-01-04 | 2022-12-30 | XMTR | Xometry, Inc. | Rollins Emily | Dir | S - Sale+OE | $32.32 | -2,000 | 3,729 | -35% | -$64.6K |
| D | 2023-01-04 | 2022-12-30 | XMTR | Xometry, Inc. | Rollins Emily | Dir | M - OptEx | $12.32 | +2,000 | 5,729 | +54% | +$24.6K |
| DM | 2022-11-28 | 2022-11-25 | XMTR | Xometry, Inc. | Rollins Emily | Dir | S - Sale+OE | $42.39 | -2,000 | 3,870 | -34% | -$84.8K |
| D | 2022-11-28 | 2022-11-25 | XMTR | Xometry, Inc. | Rollins Emily | Dir | M - OptEx | $12.32 | +2,000 | 5,729 | +54% | +$24.6K |
| DM | 2022-10-26 | 2022-10-25 | XMTR | Xometry, Inc. | Rollins Emily | Dir | S - Sale+OE | $59.30 | -2,000 | 5,484 | -27% | -$118.6K |
| D | 2022-10-26 | 2022-10-25 | XMTR | Xometry, Inc. | Rollins Emily | Dir | M - OptEx | $12.32 | +2,000 | 5,729 | +54% | +$24.6K |
| DM | 2022-09-27 | 2022-09-26 | XMTR | Xometry, Inc. | Rollins Emily | Dir | S - Sale+OE | $59.34 | -2,000 | 3,859 | -34% | -$118.7K |
| D | 2022-09-27 | 2022-09-26 | XMTR | Xometry, Inc. | Rollins Emily | Dir | M - OptEx | $12.32 | +2,000 | 5,729 | +54% | +$24.6K |
| DM | 2022-08-30 | 2022-08-26 | XMTR | Xometry, Inc. | Rollins Emily | Dir | S - Sale+OE | $46.16 | -2,000 | 3,729 | -35% | -$92.3K |
| D | 2022-08-30 | 2022-08-26 | XMTR | Xometry, Inc. | Rollins Emily | Dir | M - OptEx | $12.32 | +2,000 | 5,729 | +54% | +$24.6K |
| D | 2022-08-12 | 2022-08-10 | XMTR | Xometry, Inc. | Rollins Emily | Dir | S - Sale+OE | $50.00 | -10.0K | 3,729 | -73% | -$500.0K |
| D | 2022-08-12 | 2022-08-10 | XMTR | Xometry, Inc. | Rollins Emily | Dir | M - OptEx | $12.32 | +10.0K | 13.7K | +268% | +$123.2K |
| 2022-08-12 | 2022-08-10 | DLB | Dolby Laboratories, Inc. | Rollins Emily | Dir | S - Sale | $80.00 | -1,000 | 4,245 | -19% | -$80.0K | |
| 2022-03-17 | 2022-03-15 | XMTR | Xometry, Inc. | Rollins Emily | Dir | A - Grant | $0.00 | +3,729 | 3,729 | New | $0 | |
| D | 2022-03-02 | 2022-03-01 | XMTR | Xometry, Inc. | Rollins Emily | Dir | M - OptEx | $12.32 | +2,000 | 2,000 | New | +$24.6K |
| D | 2022-03-02 | 2022-03-01 | XMTR | Xometry, Inc. | Rollins Emily | Dir | S - Sale+OE | $50.00 | -2,000 | 0 | -100% | -$100.0K |
| 2022-02-09 | 2022-02-08 | DLB | Dolby Laboratories, Inc. | Rollins Emily | Dir | A - Grant | $0.00 | +2,783 | 5,245 | +113% | $0 |
Purchase Sale Sale after option exercise All abbreviations